Khalifa Kush, the cannabis brand founded by recording artist Wiz Khalifa, announced its continued international expansion with entry into the Australian medical cannabis market. Marking its sixth global market, Khalifa Kush will partner with cannabis company Endoca to bring its products to patients across Australia.
Through this strategic partnership, Khalifa Kush will introduce an initial portfolio of flower and edible products to the new market. The agreement provides distribution to pharmacies and clinics nationally, across all states and territories of Australia.
"Australia's well-regulated market and patient-focused approach align perfectly with our brand values – we're not entering every market, we're entering the right markets," said Khalifa Kush CEO DJ Saul in a statement. "Endoca is the perfect partner to help us maintain brand integrity and deliver the quality that patients and consumers expect from KK."
"This partnership brings an internationally recognized cannabis genetics company into Australia's regulated medical framework," said Johnny Jusic, Managing Director at Endoca, in a statement. "We're excited to work with Khalifa Kush because of the original genetics and cultivar heritage behind the brand, and our focus is on introducing that heritage to the Australian market the right way — through compliant, healthcare-led channels that meet local regulatory and manufacturing standards.
